Supernus Pharmaceuticals | SUPN - الأصول





الأصول تغيير تاريخ
Abbott USD 110.43B 23.72B 2026-03
ANI Pharmaceuticals USD 1.49B 72.14M 2026-06
Aurora Cannabis CAD 601.09M 174.2M 2026-03
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Canopy Growth CAD 1.12B 12.54M 2026-03
Cara Therapeutics USD 25.82M 6.26M 2026-03
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Eisai JPY 1.56T 108.98B 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Novo Nordisk DKK 594.94B 35.72B 2026-06
Pacira USD 1.24B 35.44M 2026-06
Perrigo USD 7.61B 373.8M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Supernus Pharmaceuticals USD 1.43B 72.62M 2026-06
United Therapeutics USD 7.22B 505.9M 2026-06
Xeris Pharmaceuticals USD 411.9M 19.89M 2026-06